SELLAS Life Sciences Group, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
SELLAS Life Sciences Group, Inc. (SLS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 2.00 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-11
- SELLAS Life Sciences Group, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 0.00 shares.
- SELLAS Life Sciences Group, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 2.00K shares.
- SELLAS Life Sciences Group, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-12-31 was 116.00K shares, a 222.22% increase year-over-year.
- SELLAS Life Sciences Group, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- SELLAS Life Sciences Group, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 3.00K shares, a 99.32% decline from fiscal 2024.
- SELLAS Life Sciences Group, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 441.00K shares, a 283.48% increase from fiscal 2023.
- SELLAS Life Sciences Group, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 115.00K shares, a 187.50% increase from fiscal 2022.
- SELLAS Life Sciences Group, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 40.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | 2.00K shares 10-Q · filed 2026-08-11 | |||
| 2026-03-31 | 2.00K shares 10-Q · filed 2026-05-12 | ||||
| 2025-12-31 | 3.00K shares 10-K · filed 2026-03-19 | ||||
| 2024-12-31 | 116.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | 116.00K shares derived: sum of 2 quarters · filed 2026-03-19 | 318.00K shares derived: sum of 3 quarters · filed 2026-03-19 | 441.00K shares 10-K · filed 2026-03-19 | |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 202.00K shares derived: sum of 2 quarters · filed 2024-11-13 | 325.00K shares 10-Q · filed 2024-11-13 | 361.00K shares derived: sum of 4 quarters · filed 2025-03-20 | |
| 2024-06-30 | 202.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 325.00K shares 10-Q · filed 2024-08-13 | 361.00K shares derived: sum of 3 quarters · filed 2025-03-20 | 383.00K shares derived: sum of 4 quarters · filed 2025-03-20 | |
| 2024-03-31 | 123.00K shares 10-Q · filed 2024-05-14 | 159.00K shares derived: sum of 2 quarters · filed 2025-03-20 | 181.00K shares derived: sum of 3 quarters · filed 2025-03-20 | 211.00K shares derived: sum of 4 quarters · filed 2025-03-20 | |
| 2023-12-31 | 36.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | 58.00K shares derived: sum of 2 quarters · filed 2025-03-20 | 88.00K shares derived: sum of 3 quarters · filed 2025-03-20 | 115.00K shares 10-K · filed 2025-03-20 | |
| 2023-09-30 | 22.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 52.00K shares derived: sum of 2 quarters · filed 2023-11-09 | 79.00K shares 10-Q · filed 2023-11-09 | 113.00K shares derived: sum of 4 quarters · filed 2024-03-28 | |
| 2023-06-30 | 30.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 57.00K shares 10-Q · filed 2023-08-10 | 91.00K shares derived: sum of 3 quarters · filed 2024-03-28 | ||
| 2023-03-31 | 27.00K shares 10-Q · filed 2023-05-11 | 61.00K shares derived: sum of 2 quarters · filed 2024-03-28 | |||
| 2022-12-31 | 34.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 40.00K shares 10-K · filed 2024-03-28 | |||
| 2022-09-30 | 6.00K shares 10-Q · filed 2022-11-14 | ||||
| 2020-03-31 | 0.00 shares 10-Q · filed 2020-05-14 | 1.74K shares derived: sum of 2 quarters · filed 2021-03-23 | -49.00K shares derived: sum of 3 quarters · filed 2021-03-23 | 3.00K shares derived: sum of 4 quarters · filed 2021-03-23 | |
| 2019-12-31 | 1.74K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | -49.00K shares derived: sum of 2 quarters · filed 2021-03-23 | 3.00K shares derived: sum of 3 quarters · filed 2021-03-23 | 5.00K shares 10-K · filed 2021-03-23 | 4.93K shares 10-K · filed 2020-03-13 |
| 2019-09-30 | -50.74K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | 1.26K shares derived: sum of 2 quarters · filed 2019-11-14 | 3.26K shares 10-Q · filed 2019-11-14 | -53.74K shares derived: sum of 4 quarters · filed 2020-03-13 | |
| 2019-06-30 | 52.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | 54.00K shares 10-Q · filed 2019-08-14 | -3.00K shares derived: sum of 3 quarters · filed 2020-03-13 | 36.00K shares derived: sum of 4 quarters · filed 2020-03-13 | |
| 2019-03-31 | 2.00K shares 10-Q · filed 2019-05-15 | -55.00K shares derived: sum of 2 quarters · filed 2020-03-13 | -16.00K shares derived: sum of 3 quarters · filed 2020-03-13 | ||
| 2018-12-31 | -57.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -18.00K shares derived: sum of 2 quarters · filed 2020-03-13 | 2.00K shares 10-K · filed 2020-03-13 | 98.00K shares 10-K · filed 2019-03-22 | |
| 2018-09-30 | 39.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | 59.00K shares 10-Q · filed 2018-11-14 | |||
| 2018-06-30 | 20.00K shares 10-Q · filed 2018-08-14 | ||||
| 2017-12-31 | -168.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-13 | -106.00K shares derived: sum of 2 quarters · filed 2018-04-13 | -18.00K shares derived: sum of 3 quarters · filed 2018-04-13 | 55.00K shares 10-K · filed 2018-04-13 | |
| 2017-09-30 | 62.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 150.00K shares derived: sum of 2 quarters · filed 2017-11-09 | 223.00K shares 10-Q · filed 2017-11-09 | -3.53M shares derived: sum of 4 quarters · filed 2017-11-09 | |
| 2017-06-30 | 88.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | 161.00K shares 10-Q · filed 2017-08-14 | -3.59M shares derived: sum of 3 quarters · filed 2017-08-14 | -2.55M shares derived: sum of 4 quarters · filed 2017-08-14 | |
| 2017-03-31 | 73.00K shares 10-Q · filed 2017-05-10 | -3.68M shares derived: sum of 2 quarters · filed 2017-05-10 | -2.64M shares derived: sum of 3 quarters · filed 2017-05-10 | -1.01M shares derived: sum of 4 quarters · filed 2017-05-10 | |
| 2016-12-31 | -3.75M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -2.71M shares derived: sum of 2 quarters · filed 2017-03-15 | -1.09M shares derived: sum of 3 quarters · filed 2017-03-15 | 240.00K shares 10-K · filed 2017-03-15 | |
| 2016-09-30 | 1.04M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | 2.67M shares derived: sum of 2 quarters · filed 2016-11-09 | 3.99M shares 10-Q · filed 2016-11-09 | 4.98M shares derived: sum of 4 quarters · filed 2016-11-09 | |
| 2016-06-30 | 1.63M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | 2.95M shares 10-Q · filed 2016-08-09 | 3.94M shares derived: sum of 3 quarters · filed 2016-08-09 | 4.12M shares derived: sum of 4 quarters · filed 2016-08-09 | |
| 2016-03-31 | 1.33M shares 10-Q · filed 2016-05-10 | 2.31M shares derived: sum of 2 quarters · filed 2016-05-10 | 2.50M shares derived: sum of 3 quarters · filed 2016-05-10 | 3.02M shares derived: sum of 4 quarters · filed 2016-05-10 | |
| 2015-12-31 | 987.00K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-04-15 | 1.17M shares derived: sum of 2 quarters · filed 2016-04-15 | 1.69M shares derived: sum of 3 quarters · filed 2016-04-15 | 2.03M shares 10-K/A · filed 2016-04-15 | |
| 2015-09-30 | 185.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | 707.00K shares derived: sum of 2 quarters · filed 2015-11-09 | 1.04M shares 10-Q · filed 2015-11-09 | 1.59M shares derived: sum of 4 quarters · filed 2015-12-04 | |
| 2015-06-30 | 522.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | 860.00K shares 10-Q · filed 2015-08-06 | 1.40M shares derived: sum of 3 quarters · filed 2015-12-04 | 2.70M shares derived: sum of 4 quarters · filed 2015-12-04 | |
| 2015-03-31 | 338.00K shares 10-Q · filed 2015-05-07 | 882.00K shares derived: sum of 2 quarters · filed 2015-12-04 | 2.17M shares derived: sum of 3 quarters · filed 2015-12-04 | 2.60M shares derived: sum of 4 quarters · filed 2015-12-04 | |
| 2014-12-31 | 544.00K shares derived: 8-K 12 month − 10-Q 9 month · filed 2015-12-04 | 1.84M shares derived: sum of 2 quarters · filed 2015-12-04 | 2.26M shares derived: sum of 3 quarters · filed 2015-12-04 | 2.34M shares 8-K · filed 2015-12-04 | |
| 2014-09-30 | 1.29M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | 1.72M shares derived: sum of 2 quarters · filed 2014-11-05 | 1.79M shares 10-Q · filed 2014-11-05 | 2.61M shares derived: sum of 4 quarters · filed 2014-11-05 | |
| 2014-06-30 | 425.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | 500.00K shares 10-Q · filed 2014-08-11 | 1.32M shares derived: sum of 3 quarters · filed 2014-08-11 | 1.36M shares derived: sum of 4 quarters · filed 2014-08-11 | |
| 2014-03-31 | 75.00K shares 10-Q · filed 2014-05-06 | 895.00K shares derived: sum of 2 quarters · filed 2014-05-06 | 937.00K shares derived: sum of 3 quarters · filed 2014-05-06 | 1.02M shares derived: sum of 4 quarters · filed 2014-05-06 | |
| 2013-12-31 | 820.00K shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2014-03-17 | 862.00K shares derived: sum of 2 quarters · filed 2014-03-17 | 943.90K shares derived: sum of 3 quarters · filed 2014-03-17 | 1.34M shares 10-K · filed 2014-03-17 | |
| 2013-09-30 | 42.00K shares derived: 10-Q/A 9 month − 10-Q 6 month · filed 2013-11-07 | 123.90K shares derived: sum of 2 quarters · filed 2013-11-07 | 517.00K shares 10-Q/A · filed 2013-11-07 | 1.04M shares derived: sum of 4 quarters · filed 2013-11-07 | |
| 2013-06-30 | 81.90K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | 475.00K shares 10-Q · filed 2013-08-09 | 1.00M shares derived: sum of 3 quarters · filed 2013-08-09 | 700.60K shares derived: sum of 4 quarters · filed 2013-08-09 | |
| 2013-03-31 | 393.10K shares 10-Q · filed 2013-05-09 | 919.73K shares derived: sum of 2 quarters · filed 2013-05-09 | 618.70K shares derived: sum of 3 quarters · filed 2013-05-09 | ||
| 2012-12-31 | 526.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | 225.60K shares derived: sum of 2 quarters · filed 2013-03-12 | 264.82K shares 10-K · filed 2013-03-12 | ||
| 2012-09-30 | -301.04K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | -261.82K shares 10-Q · filed 2012-11-13 | |||
| 2012-06-30 | 39.22K shares 10-Q · filed 2012-08-14 | ||||
| 2011-12-31 | 1.49M shares 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |